
Hosted by JAMA Network · EN
In this episode of JAMA+ AI Conversations, Roy Perlis, MD, MSc, and Yulin Hswen, ScD, MPH, discuss Anthropic's participation in the Vatican presentation of Pope Leo XIV's AI encyclical, Magnifica Humanitas. The conversation explores AI ethics, interpretability, governance, AI safety, and the growing role of health care, public health, and global institutions in shaping the future of AI. Related Content: From Silicon Valley to the Vatican—The Expanding Debate on AI Ethics
Is it enough for AI to be accurate, or are we mistaking performance for impact? Does AI change clinician behavior, improve patient decisions, or simply create a convincing performance of intelligence? Yun Liu, PhD, research scientist at Google Research, speaks with JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, about what is behind the curtain in these AI systems. Related Content: The Wizard of Oz in Medical AI
Every patient has a story, but in modern health care that story is buried across thousands of notes, lab results, and fragmented records. Nigam H. Shah, MBBS, PhD, of Stanford University Department of Medicine joins JAMA Associate Editor Yulin Hswen, ScD, MPH, to explore how researchers are building AI systems that can read and understand a patient's full medical history in seconds. Related Content: Chatting With AI and the Electronic Health Record
Join JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, for a conversation about the practical implementation of trustworthy clinical AI. Guests Emily Tat, MD, and Peter Brodeur, MD, discuss ARISE, a research network focused on the real-world effects of AI on clinical care. Related Content: Designing Trustworthy Clinical AI
As artificial intelligence increasingly shapes population health decisions, evidence and accuracy matter. In this episode of JAMA+ AI Conversations, Associate Editor Yulin Hswen, ScD, MPH, speaks with Sandro Galea, MD, MPH, DrPH, Editor of JAMA Health Forum, about how AI is entering health policy, when it is ready for use, and what rigorous, policy-focused AI research is most needed. Related Content: AI at the Policy Table
Why can signals that appear consistent across many studies still reflect shared bias; how do sibling comparisons help recalibrate cumulative evidence; and what AI-enabled approaches can add to large-scale evidence integration? Viktor H. Ahlqvist, PhD, from the Karolinska Institute joins JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, to discuss why automated drug safety surveillance during pregnancy is urgently needed and how AI and computation can strengthen or undermine causal inference. Related Content: AI Drug Safety in Pregnancy
How might AI amplify epidemiological insight into neurodegenerative and systemic disease? JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, speaks with Fang Fang, MD, PhD, professor at Karolinska Institutet and head of the Integrative Epidemiology group. Drawing on Fang Fang's work in ALS, Parkinson disease, dementia, energy metabolism, immune modulation, and gut microbiome interactions, their conversation probes how AI methods might help map disease trajectories, identify prognostic markers, and ultimately support precision prevention and translational research, while preserving scientific rigor and interpretability. Related Content: AI and the Epidemiology of Complex Disease
What are the safety, evidence standards, and transparency needed for AI chatbots used in mental health contexts, particularly for young people. John Torous, MD, MBI, JAMA Psychiatry Author Interviews podcast host, joins JAMA+ AI Associate Editor Yulin Hswen, ScD, to discuss risks, data protections, and the clinical safeguards required to ensure responsible use. Related Content: AI Chatbots and Youth Mental Health
Dr Robert Wachter, chair of the Department of Medicine at UC San Francisco, speaks with JAMA+ AI Editor in Chief Roy Perlis about his new book, "A Giant Leap." Their discussion addresses multiple potential impacts of AI in medicine in terms of clinical practice but also training the next generation of clinicians. Related Content: Leaping Forward Into…What?—An Interview With Robert M. Wachter
In this episode, JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, speaks with David Wu, MD, PhD, and Adam Rodman, MD, MPH, about what safe clinical use of LLMs requires. Drawing on the framework of Do No Harm, they examine failure modes, limits of accuracy-based evaluation, clinician AI interaction, and safeguards needed as medical AI moves into patient care. Related Content: From AI Bench to AI Bedside